Wellington Management

Wellington Management Company, founded in 1928 and headquartered in Boston, Massachusetts, is an investment management firm that caters to a diverse range of institutional clients, including high-net-worth individuals, pension plans, endowments, insurers, and government entities. The firm employs a comprehensive approach to investment management that encompasses equity, fixed income, currency, commodity, and alternative markets. Wellington Management offers various services, including asset allocation, multi-manager strategies, and specialized investment approaches. The firm is known for its focus on both growth and value stocks across small-cap, mid-cap, and large-cap companies, and it manages a variety of investment vehicles, such as mutual funds and hedge funds, to meet the unique needs of its clientele.

Kelly McDonnell

Vice President

Prakhar Singh

Principal, Private Equity and Sector Lead, Asia

Past deals in Colorado

Meati

Series C in 2022
Meati Foods is a consumer goods company based in Boulder, Colorado, that specializes in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide nutrient-dense, plant-based options that serve as sustainable substitutes for traditional meat. Meati's products are crafted using proprietary fermentation technologies and are minimally processed, ensuring they are free from common allergens. The company is committed to offering vegan food choices that are accessible and enjoyable for a diverse range of consumers.

Edgewise Therapeutics

Series C in 2020
Edgewise Therapeutics, founded in 2017 and based in Boulder, Colorado, is a clinical-stage biopharmaceutical company dedicated to developing precision medicine therapies for severe, rare muscle disorders. The company's core expertise lies in muscle biology and small molecule engineering, which it employs through its proprietary drug discovery platform. This platform uses custom-built systems to measure integrated muscle function, enabling the identification of small molecule therapies targeting key proteins in muscle tissue. Edgewise's pipeline focuses on addressing genetically defined muscle disorders such as Duchenne muscular dystrophy, Becker muscular dystrophy, and limb-girdle muscular dystrophies.

ezCater

Series D in 2019
ezCater, Inc. is an online catering marketplace that facilitates food ordering for both small startups and large corporations. Founded in 2007 and headquartered in Boston, Massachusetts, with an additional office in Denver, the company connects businesses with local caterers and restaurants across the nation. ezCater offers a platform that allows users to easily find and order food for meetings and events, utilizing features that filter caterers by food type, budget, and other criteria. The company's solutions include ezManage, a catering management platform, and ezOrdering, which enables restaurants to accept catering orders directly through their websites. By streamlining the catering process, ezCater helps clients save time and efficiently select suitable catering options.

ezCater

Series D in 2018
ezCater, Inc. is an online catering marketplace that facilitates food ordering for both small startups and large corporations. Founded in 2007 and headquartered in Boston, Massachusetts, with an additional office in Denver, the company connects businesses with local caterers and restaurants across the nation. ezCater offers a platform that allows users to easily find and order food for meetings and events, utilizing features that filter caterers by food type, budget, and other criteria. The company's solutions include ezManage, a catering management platform, and ezOrdering, which enables restaurants to accept catering orders directly through their websites. By streamlining the catering process, ezCater helps clients save time and efficiently select suitable catering options.

Nivalis Therapeutics

Venture Round in 2014
Nivalis Therapeutics is a biotechnology company focused on developing innovative disease-modifying therapies aimed at cystic fibrosis (CF). The company is particularly dedicated to preserving intracellular S-nitrosoglutathione (GSNO), a naturally occurring molecule that plays a crucial role in cell signaling and is linked to the pathophysiology of CF. Its lead therapeutic candidate, N91115, specifically targets patients with the F508del mutation, which is the most prevalent mutation responsible for cystic fibrosis. Founded in 2007 and based in Boulder, Colorado, Nivalis Therapeutics aims to significantly improve the quality of life for individuals affected by cystic fibrosis and their families.

Datalogix

Series C in 2014
Datalogix is a prominent company specializing in connecting digital media with offline purchasing data, enabling marketers to enhance the effectiveness and measurability of their advertising efforts. The company serves more than half of the top 100 consumer marketers and manages the DLX Platform, which encompasses over $1 trillion in consumer spending and supports campaigns for a significant majority of online media companies. Datalogix's DLX ROI is becoming a standard for measuring the impact of digital media on offline sales. Additionally, the company provides predictive analytics for direct mail and integrated media solutions through the DLX Net. Its expertise covers various consumer sectors, including retail, consumer packaged goods, automotive, telecommunications, travel, and financial services. Headquartered in Colorado, Datalogix has established offices in key cities such as New York City, San Francisco, Boston, Chicago, Detroit, and London.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.